The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olanzapine or dexamethasone, with 5-HT3 receptor antagonist and NK-1 receptor antagonist, to prevent nausea and vomiting induced by cisplatin-based doublet chemotherapy: A non-inferiority, prospective, multi-centered, randomized, controlled, phase III clinical trial.
 
Zhigang Liu
No Relationships to Disclose
 
Yuling Zhou
No Relationships to Disclose
 
Shuang Yang
No Relationships to Disclose
 
Wei-neng Feng
No Relationships to Disclose
 
Ming-Yuan Chen
No Relationships to Disclose
 
Xiong Zou
No Relationships to Disclose
 
Guang Han
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Guorong Zou
No Relationships to Disclose
 
Yu-Xiang He
No Relationships to Disclose
 
Lemeng Zhang
No Relationships to Disclose
 
Lei Cui
No Relationships to Disclose
 
Hualin Chen
No Relationships to Disclose
 
Guo Li
No Relationships to Disclose
 
Shan Jiang
No Relationships to Disclose
 
Jin Gao
No Relationships to Disclose
 
Lin Xiao
No Relationships to Disclose
 
Qun Zhang
No Relationships to Disclose
 
Wei Yi
No Relationships to Disclose
 
Chenghui Huang
No Relationships to Disclose